139 related articles for article (PubMed ID: 22365452)
1. Hydroxyfasudil ameliorates bladder dysfunction in male spontaneously hypertensive rats.
Inoue S; Saito M; Takenaka A
Urology; 2012 May; 79(5):1186.e9-14. PubMed ID: 22365452
[TBL] [Abstract][Full Text] [Related]
2. Nicorandil ameliorates hypertension-related bladder dysfunction in the rat.
Saito M; Ohmasa F; Tsounapi P; Inoue S; Dimitriadis F; Kinoshita Y; Satoh K
Neurourol Urodyn; 2012 Jun; 31(5):695-701. PubMed ID: 22473863
[TBL] [Abstract][Full Text] [Related]
3. Effect of silodosin on detrusor overactivity in the male spontaneously hypertensive rat.
Inoue S; Saito M; Tsounapi P; Dimitriadis F; Ohmasa F; Kinoshita Y; Satoh K; Takenaka A
BJU Int; 2012 Jul; 110(2 Pt 2):E118-24. PubMed ID: 22146017
[TBL] [Abstract][Full Text] [Related]
4. Characterization of silodosin and naftopidil in the treatment of bladder dysfunction in the spontaneously hypertensive rat.
Saito M; Shimizu S; Ohmasa F; Oikawa R; Tsounapi P; Dimitriadis F; Kinoshita Y; Satoh K
Neurourol Urodyn; 2013 Apr; 32(4):393-8. PubMed ID: 22907830
[TBL] [Abstract][Full Text] [Related]
5. Olmesartan ameliorates urinary dysfunction in the spontaneously hypertensive rat via recovering bladder blood flow and decreasing oxidative stress.
Shimizu S; Saito M; Oiwa H; Ohmasa F; Tsounapi P; Oikawa R; Dimitriadis F; Martin DT; Satoh I; Kinoshita Y; Tomita S
Neurourol Urodyn; 2014 Mar; 33(3):350-7. PubMed ID: 23775684
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of hydroxyfasudil, a Rho kinase inhibitor, on ventral prostatic hyperplasia in the spontaneously hypertensive rat.
Holmström F; Shimizu S; Shimizu T; Higashi Y; Martin DT; Honda M; Saito M
Prostate; 2015 Nov; 75(15):1774-82. PubMed ID: 26286428
[TBL] [Abstract][Full Text] [Related]
7. Hydroxyfasudil ameliorates penile dysfunction in the male spontaneously hypertensive rat.
Saito M; Ohmasa F; Dimitriadis F; Tsounapi P; Sejima T; Shimizu S; Kinoshita Y; Satoh K
Pharmacol Res; 2012 Oct; 66(4):325-31. PubMed ID: 22750666
[TBL] [Abstract][Full Text] [Related]
8. Effect of the rho-kinase inhibitor hydroxyfasudil on bladder overactivity: an experimental rat model.
Masago T; Watanabe T; Saito M; Kinoshita Y; Sato K; Miyagawa I
Int J Urol; 2009 Oct; 16(10):842-7. PubMed ID: 19735460
[TBL] [Abstract][Full Text] [Related]
9. Effects of the Rho kinase inhibitor, hydroxyfasudil, on bladder dysfunction and inflammation in rats with HCl-induced cystitis.
Shimizu N; De Velasco MA; Umekawa T; Uemura H; Yoshikawa K
Int J Urol; 2013 Nov; 20(11):1136-43. PubMed ID: 23419011
[TBL] [Abstract][Full Text] [Related]
10. Rho-kinase inhibition suppresses bladder hyperactivity in spontaneously hypertensive rats.
Rajasekaran M; Wilkes N; Kuntz S; E Albo M
Neurourol Urodyn; 2005; 24(3):295-300. PubMed ID: 15791631
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the urinary bladder dysfunction in renovascular hypertensive rats.
Ramos-Filho AC; Mónica FZ; Franco-Penteado CF; Rojas-Moscoso JA; Báu FR; Schenka AA; De Nucci G; Antunes E
Neurourol Urodyn; 2011 Sep; 30(7):1392-402. PubMed ID: 21661033
[TBL] [Abstract][Full Text] [Related]
12. Stretch-activated signaling of nerve growth factor secretion in bladder and vascular smooth muscle cells from hypertensive and hyperactive rats.
Clemow DB; Steers WD; Tuttle JB
J Cell Physiol; 2000 Jun; 183(3):289-300. PubMed ID: 10797303
[TBL] [Abstract][Full Text] [Related]
13. Altered NGF regulation may link a genetic predisposition for hypertension with hyperactive voiding.
Clemow DB; Spitsbergen JM; McCarty R; Steers WD; Tuttle JB
J Urol; 1999 Apr; 161(4):1372-7. PubMed ID: 10081910
[TBL] [Abstract][Full Text] [Related]
14. Modulation of detrusor contraction strength and micturition characteristics by intrathecal baclofen in anesthetized rats.
Watanabe T; Perkash I; Constantinou CE
J Urol; 1997 Jun; 157(6):2361-5. PubMed ID: 9146671
[TBL] [Abstract][Full Text] [Related]
15. Neurally mediated hyperactive voiding in spontaneously hypertensive rats.
Spitsbergen JM; Clemow DB; McCarty R; Steers WD; Tuttle JB
Brain Res; 1998 Apr; 790(1-2):151-9. PubMed ID: 9593870
[TBL] [Abstract][Full Text] [Related]
16. Identification of potential therapeutic targets in hypertension-associated bladder dysfunction.
Yono M; Yoshida M; Yamamoto Y; Imanishi A; Fukagawa A; Latifpour J; Eto M
BJU Int; 2010 Mar; 105(6):877-83. PubMed ID: 19689474
[TBL] [Abstract][Full Text] [Related]
17. Underlying mechanisms of urine storage dysfunction in rats with salt-loading hypertension.
Kurokawa T; Zha X; Ito H; Aoki Y; Akino H; Kobayashi M; Yokoyama O
Life Sci; 2015 Nov; 141():8-12. PubMed ID: 26390819
[TBL] [Abstract][Full Text] [Related]
18. Fasudil improves the endothelial dysfunction in the aorta of spontaneously hypertensive rats.
Tsounapi P; Saito M; Kitatani K; Dimitriadis F; Ohmasa F; Shimizu S; Kinoshita Y; Takenaka A; Satoh K
Eur J Pharmacol; 2012 Sep; 691(1-3):182-9. PubMed ID: 22819709
[TBL] [Abstract][Full Text] [Related]
19. [Effects and mechanisms of phosphodiesterase type 5 inhibitors on rats with overactive bladder].
Chen HD; Ye XT; Weng ZL; Li CD
Zhonghua Yi Xue Za Zhi; 2011 Jul; 91(28):2001-5. PubMed ID: 22093899
[TBL] [Abstract][Full Text] [Related]
20. A role for muscarinic receptors or rho-kinase in hypertension associated rat bladder dysfunction?
Schneider T; Hein P; Bai J; Michel MC
J Urol; 2005 Jun; 173(6):2178-81. PubMed ID: 15879883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
